# KAERVAX — Phase 2 Execution Report

## EXECUTION REPORT

**Phase:** 2 — Canonical Domain

**Gate:** G2

**Status:** **PASS**

**Assessment date:** 2026-09-18

## 1. Sprint Results

- **Sprint 2.1 — PASS:** Established a vendor-neutral domain kernel for 11 stateful concepts plus `AuditEvent`, with KAERVAX-owned IDs, provenance, evidence classes, explicit relationships, domain-controlled core fields, and documented deferrals.
- **Sprint 2.2 — PASS:** Defined lifecycle states and allowed transitions; tested valid transitions, invalid/terminal transitions, relationship invariants, approval prerequisites, and future-phase payment/connector blocks.
- **Sprint 2.3 — PASS:** Implemented bounded pure commands for creation and transitions; every supported mutation returns a reference-based audit event. No persistence, external execution, payment authority, or broad command framework was added.

## 2. Canonical Artifacts

- `src/domain/index.js` — canonical concepts, states, transition maps, invariants, commands, audit event semantics, and Phase 2 policy.
- `tests/domain.test.mjs` — synthetic domain fixtures and deterministic domain tests.
- `docs/phase-2/43_CANONICAL_DOMAIN_CONTRACT.md` — ownership, concepts, lifecycle, command, audit, security, and deferral contract.
- `docs/phase-2/44_G2_GATE_ASSESSMENT.md` — evidence-mapped G2 decision.
- `public/index.html` and `public/health.json` — public-safe Phase 2/G2 status with unchanged G0 boundary.

## 3. Files Changed

- `src/domain/index.js`
- `tests/domain.test.mjs`
- `tests/foundation.test.mjs`
- `scripts/verify-build.mjs`
- `public/index.html`
- `public/health.json`
- `ecosystem.config.cjs`
- `package.json`
- `README.md`
- `docs/phase-2/43_CANONICAL_DOMAIN_CONTRACT.md`
- `docs/phase-2/44_G2_GATE_ASSESSMENT.md`
- `docs/phase-2/45_PHASE_2_EXECUTION_REPORT.md`

## 4. Tests and Actual Results

- `npm run verify` before commit — PASS: build artifacts verified; 19 tests passed, 0 failed, 0 skipped.
- `npm run verify` immediately before production deploy — PASS: build artifacts verified; 19 tests passed, 0 failed, 0 skipped.
- `npm audit --audit-level=high` — PASS: zero vulnerabilities.
- Worktree/staged credential-pattern scans — PASS: no match.
- Tracked secret-file check — PASS: no tracked local environment/private-key file.
- PM2 preview — PASS: `kaervax-canonical-domain` online on port 3000.
- Local `/` and `/health.json` — HTTP 200 with Phase 2, G2 PASS, and G0 PARTIAL / BLOCKED.
- Browser preview — expected title and `#page-title` rendered; zero console messages.
- Production `https://kaervax.pages.dev` — HTTP 200; Phase 2/G2/G0 text, health payload, and CSP observed.
- Custom domain `https://kaervax.biz.id` — HTTP 200 with matching Phase 2 page and health payload.
- Deployment URL `https://de591295.kaervax.pages.dev` — HTTP 200 with matching Phase 2 page and health payload.

### Failed and recovered during implementation

1. Initial domain run: 16 passed, 1 failed because the demand-specific command did not yet scan problem/outcome values for credential-shaped content. The boundary was corrected and retested.
2. Expanded invariant run: 18 passed, 1 failed because a test fixture lacked required `Offer.version`. The fixture was corrected; the invariant was not weakened.
3. Initial commit attempt stopped on Markdown trailing whitespace. Formatting was corrected before commit.

## 5. Security Impact

- No application or deployment secret was added.
- Secret-shaped fields and recognized credential-shaped values are rejected from domain/audit data.
- Provider credentials remain outside canonical records.
- Human operator plus approval reference is required to approve an `Action`.
- No external action execution command exists.
- `PAID`/`REFUNDED` and connector execution transitions remain blocked in the command path.
- The production surface remains static, public, and read-only with the existing security headers.

## 6. Data / Migration Impact

- **Database:** deferred.
- **Migrations:** not introduced.
- **Durable audit storage:** deferred.
- **Authentication/authorization runtime:** deferred; no protected/mutating HTTP route exists.
- No production business data was created or modified.

## 7. Deployment Impact

- Cloudflare authentication used the approved BYOK boundary.
- Existing Pages project `kaervax` was reused; no new project or binding was created.
- No D1/KV/R2 binding, secret, migration, or destructive operation was required.
- Production deployment completed at `https://de591295.kaervax.pages.dev`.
- Canonical production remains `https://kaervax.pages.dev`; custom domain `https://kaervax.biz.id` is also verified.
- Recovery remains rebuild/redeploy of a known verified Git commit.

## 8. Evidence

### OBSERVED

Repository/branch/history and governing documents; G0/G1 evidence; actual source and tests; Node build/test/audit output; deterministic domain rejection behavior; local PM2/HTTP/browser results; Git commit; Wrangler account/project/deploy responses; and production/custom-domain HTTP responses.

### DERIVED

A pure domain kernel is sufficient for G2 and safer than adding a database or public mutation API. Explicitly blocked payment/connector transitions preserve later-phase authority boundaries while still documenting vendor-neutral state vocabulary.

### SYNTHETIC

All business examples and IDs in domain tests are fixtures marked `SYNTHETIC`. They are not buyer, demand, payment, delivery, acceptance, or commercial evidence.

## 9. Blockers and Unresolved Decisions

- No technical blocker prevents G2 PASS within Phase 2 scope.
- Durable persistence, auth, demand ingestion, scoring, connector execution, payment verification, delivery automation, and learning automation remain unresolved by design and require later authorization.
- G0 blockers remain: no authorized buyer interaction/response and no verified first-trial payment authority path.

## 10. Gate Independence

- **G0:** remains **PARTIAL / BLOCKED**.
- **G1:** remains **PASS**.
- **G2:** **PASS**.

> **G2 PASS = canonical-domain readiness only. It does not mean G0 passed and it does not authorize Phase 3 automatically.**

## 11. Commit

- Verified and deployed Phase 2 implementation commit: `c6dad0a35c3a53973c1dad1f3d7ada93a431fd98`.
- Final report/README close-out is a separate documentation commit recorded in Git history after deployment verification.

## 12. Next Decision

Stop at G2. The operator must separately decide whether to authorize Phase 3. Independently, the commercial track should address G0 through an approved real buyer interaction and verified payment-authority path.

---

## Session Contract — PH2-20260918-01

```text
SESSION ID: PH2-20260918-01
PHASE: 2
GATE: G2
SPRINT: 2.1 — Domain Model
OBJECTIVE: Establish the smallest vendor-neutral canonical model with explicit KAERVAX ownership.
INPUTS: Actual main branch, master prompt, governance, roadmap, G0/G1 evidence, existing static foundation.
DOCS USED: docs/39, docs/42, 37, 38, 06, 07, 08, 11, docs/phase-0/44, docs/phase-1/42-44.
FILES / SYSTEMS AFFECTED: src/domain/index.js, tests/domain.test.mjs, docs/phase-2/43_CANONICAL_DOMAIN_CONTRACT.md.
IMPLEMENTATION OR OPERATING ACTION: Modeled 11 stateful concepts plus AuditEvent, common canonical fields, provenance/evidence, required relationships, and explicit deferrals.
TEST / VERIFICATION: Minimum construction for every stateful concept; canonical ownership/ID separation and reserved-field checks passed.
EVIDENCE: OBSERVED code/test output; DERIVED persistence deferral; SYNTHETIC entity fixtures only.
SECURITY IMPACT: Provider credentials excluded; no public/stateful runtime introduced.
DATA / MIGRATION IMPACT: Database and migrations remain deferred.
DEPLOYMENT IMPACT: No runtime dependency or binding added.
RISKS: Pure in-memory return values are not durable and are not represented as durable.
BLOCKERS: N/A within Sprint 2.1.
RESULT: PASS.
COMMIT: c6dad0a35c3a53973c1dad1f3d7ada93a431fd98.
NEXT DECISION: Enforce explicit lifecycle rules.
NEXT SESSION: PH2-20260918-02.
```

## Session Contract — PH2-20260918-02

```text
SESSION ID: PH2-20260918-02
PHASE: 2
GATE: G2
SPRINT: 2.2 — Lifecycle Rules
OBJECTIVE: Define and enforce valid transitions and reject invalid or premature transitions.
INPUTS: Sprint 2.1 records, governance approval/payment/connector boundaries.
DOCS USED: docs/39, docs/42, 06, 07, 08, 11, 37, 38.
FILES / SYSTEMS AFFECTED: src/domain/index.js, tests/domain.test.mjs, docs/phase-2/43_CANONICAL_DOMAIN_CONTRACT.md.
IMPLEMENTATION OR OPERATING ACTION: Added explicit state maps, transition maps, terminal behavior, relationship/state invariants, approval preconditions, payment and connector future-phase blocks.
TEST / VERIFICATION: Valid demand transition, invalid transition, terminal transition, offer/opportunity approval, worker approval bypass, payment, and connector rejection tests passed.
EVIDENCE: OBSERVED deterministic test outcomes; SYNTHETIC fixtures only.
SECURITY IMPACT: Human approval boundary enforced for consequential Action approval.
DATA / MIGRATION IMPACT: N/A; pure domain logic only.
DEPLOYMENT IMPACT: No external behavior added.
RISKS: Later phases must not remove authoritative verification blocks without new tests and authorization.
BLOCKERS: N/A within Sprint 2.2.
RESULT: PASS.
COMMIT: c6dad0a35c3a53973c1dad1f3d7ada93a431fd98.
NEXT DECISION: Establish bounded commands and audit semantics.
NEXT SESSION: PH2-20260918-03.
```

## Session Contract — PH2-20260918-03

```text
SESSION ID: PH2-20260918-03
PHASE: 2
GATE: G2
SPRINT: 2.3 — Commands + Audit
OBJECTIVE: Ensure supported state changes validate intent/actor/invariants and produce safe audit descriptions.
INPUTS: Sprint 2.1 model and Sprint 2.2 lifecycle.
DOCS USED: docs/39, docs/42, 06, 08, 11, 37, 38.
FILES / SYSTEMS AFFECTED: src/domain/index.js, tests/domain.test.mjs, docs/phase-2/43_CANONICAL_DOMAIN_CONTRACT.md.
IMPLEMENTATION OR OPERATING ACTION: Implemented CreateDemandSignal, generic bounded creation, TransitionEntity, and reference-based AuditEvent output; omitted patch/execution/payment commands.
TEST / VERIFICATION: Actor/input/secret/reserved-field checks and audit state-delta/reference tests passed.
EVIDENCE: OBSERVED 19-test final suite and actual command errors.
SECURITY IMPACT: Secret-like domain/audit data rejected; no secret-bearing audit snapshots.
DATA / MIGRATION IMPACT: Durable audit persistence explicitly deferred.
DEPLOYMENT IMPACT: Static status/health only; no command API exposed.
RISKS: Future application adapters must persist entity and audit outcome atomically once persistence is authorized.
BLOCKERS: N/A within Sprint 2.3.
RESULT: PASS.
COMMIT: c6dad0a35c3a53973c1dad1f3d7ada93a431fd98.
NEXT DECISION: Assess G2 from verified evidence.
NEXT SESSION: PH2-20260918-G2.
```

## Session Contract — PH2-20260918-G2

```text
SESSION ID: PH2-20260918-G2
PHASE: 2
GATE: G2
SPRINT: Gate assessment and release
OBJECTIVE: Assess G2, publish verified artifacts, and stop at the gate.
INPUTS: Sprint 2.1-2.3 outputs, tests, local preview, Git state, BYOK deployment, production verification.
DOCS USED: docs/39, docs/42, 37, 38, docs/phase-0/44, docs/phase-1/43, docs/phase-2/43-44.
FILES / SYSTEMS AFFECTED: README.md, public status/health, GitHub main, Cloudflare Pages kaervax.
IMPLEMENTATION OR OPERATING ACTION: Ran full verification, committed the release, deployed through BYOK, and verified Pages/custom/deployment URLs.
TEST / VERIFICATION: 19/19 tests passed; local and three production URLs returned expected Phase 2 state.
EVIDENCE: OBSERVED Git, Wrangler, Cloudflare, HTTP, and browser results; no synthetic gate-pass evidence.
SECURITY IMPACT: BYOK/GitHub credentials remained outside Git; zero vulnerabilities and no credential-pattern match.
DATA / MIGRATION IMPACT: N/A; persistence remains deferred.
DEPLOYMENT IMPACT: Phase 2 status active at kaervax.pages.dev and kaervax.biz.id.
RISKS: Commit-based redeploy remains the recovery contract; provider dashboard rollback was not exercised.
BLOCKERS: G0 commercial blockers remain independent.
RESULT: PASS.
COMMIT: c6dad0a35c3a53973c1dad1f3d7ada93a431fd98 plus final documentation commit.
NEXT DECISION: Stop at G2; Phase 3 requires separate authorization.
NEXT SESSION: N/A until an explicit decision.
```
